Tooltip
.tooltip {
position: relative;
cursor: pointer;
text-decoration: none;
border-bottom: 1px dashed rgba(0, 0, 0, 0.6);
}
.tooltip::before {
content: attr(data-tooltip);
position: absolute;
top: -40px; /* Trochę niżej nad słowem */
left: 50%; /* Wyśrodkowanie */
transform: translateX(-50%);
background-color: rgba(255, 255, 255, 0.9);
color: #333;
padding: 6px 12px;
border-radius: 8px;
white-space: nowrap;
opacity: 0;
visibility: hidden;
transition: opacity 0.3s ease, visibility 0.3s ease;
font-family: ‘Arial’, sans-serif;
font-size: 14px;
box-shadow: 0px 4px 8px rgba(0, 0, 0, 0.1);
z-index: 10;
}
.tooltip:hover::before {
opacity: 1;
visibility: visible;
}
document.addEventListener(‘DOMContentLoaded’, function () {
const wordsToTooltip = {
“allergic diseases”: “choroby alergiczne”,
“exaggerated immune response”: “nadmierna reakcja immunologiczna”,
“allergens”: “alergeny”,
“allergic rhinitis”: “alergiczny nieżyt nosa”,
“hay fever”: “katar sienny”,
“nasal mucosa”: “błona śluzowa nosa”,
“sneezing”: “kichanie”,
“nasal congestion”: “zatkany nos”,
“runny nose”: “katar”,
“itchy, watery eyes”: “swędzące, łzawiące oczy”,
“seasonal”: “sezonowy”,
“perennial”: “całoroczny”,
“immunoglobulin E”: “immunoglobulina E”,
“histamine”: “histamina”,
“vasodilation”: “rozszerzenie naczyń”,
“vascular permeability”: “przepuszczalność naczyń”,
“asthma”: “astma”,
“chronic inflammatory disease”: “przewlekła choroba zapalna”,
“wheezing”: “świszczący oddech”,
“bronchoconstriction”: “skurcz oskrzeli”,
“airway swelling”: “obrzęk dróg oddechowych”,
“mucus production”: “produkcja śluzu”,
“atopic dermatitis”: “atopowe zapalenie skóry”,
“eczema”: “wyprysk”,
“red, inflamed patches”: “czerwone, zapalne plamy”,
“secondary infections”: “wtórne infekcje”,
“compromised skin barrier”: “osłabiona bariera skórna”,
“food allergies”: “alergie pokarmowe”,
“anaphylaxis”: “anafilaksja”,
“autoimmune disorders”: “choroby autoimmunologiczne”,
“immune response”: “odpowiedź immunologiczna”,
“genetic predisposition”: “predyspozycja genetyczna”,
“systemic lupus erythematosus”: “toczeń rumieniowaty układowy”,
“rheumatoid arthritis”: “reumatoidalne zapalenie stawów”,
“autoantibodies”: “autoprzeciwciała”,
“nuclear antigens”: “antygeny jądrowe”,
“immune complexes”: “kompleksy immunologiczne”,
“exacerbation and remission”: “zaostrzenia i remisje”,
“sunlight exposure”: “ekspozycja na słońce”,
“hormonal influences”: “wpływy hormonalne”,
“estrogen”: “estrogen”,
“immune complex deposition”: “depozyty kompleksów immunologicznych”,
“constitutional symptoms”: “objawy ogólne”,
“photosensitivity”: “nadwrażliwość na światło”,
“discoid lupus erythematosus”: “toczeń rumieniowaty krążkowy”,
“lupus nephritis”: “nefropatia toczniowa”,
“proteinuria”: “białkomocz”,
“anemia”: “niedokrwistość”,
“leukopenia”: “leukopenia”,
“thrombocytopenia”: “małopłytkowość”,
“antinuclear antibody test”: “badanie przeciwciał przeciwjądrowych”,
“anti-dsDNA”: “przeciwciała przeciw dwuniciowemu DNA”,
“Smith antigen”: “antygen Smitha”,
“nonsteroidal anti-inflammatory drugs”: “niesteroidowe leki przeciwzapalne”,
“hydroxychloroquine”: “hydroksychlorochina”,
“azathioprine”: “azatiopryna”,
“mycophenolate mofetil”: “mykofenolan mofetylu”,
“cyclophosphamide”: “cyklofosfamid”,
“sun exposure”: “ekspozycja na słońce”,
“cardiovascular disease”: “choroba sercowo-naczyniowa”,
“atherosclerosis”: “miażdżyca”,
“rheumatoid arthritis”: “reumatoidalne zapalenie stawów”,
“synovitis”: “zapalenie błony maziowej”,
“pannus”: “pannus”,
“tumor necrosis factor-alpha”: “czynnik martwicy nowotworów alfa”,
“interleukin-6”: “interleukina-6”,
“symmetrical polyarthritis”: “symetryczne zapalenie wielostawowe”,
“morning stiffness”: “sztywność poranna”,
“rheumatoid nodules”: “guzki reumatoidalne”,
“interstitial lung disease”: “śródmiąższowa choroba płuc”,
“erythrocyte sedimentation rate”: “odczyn Biernackiego”,
“C-reactive protein”: “białko C-reaktywne”,
“disease-modifying antirheumatic drugs”: “leki modyfikujące przebieg choroby reumatycznej”,
“methotrexate”: “metotreksat”,
“TNF inhibitors”: “inhibitory TNF”,
“etanercept”: “etanercept”,
“infliximab”: “infliksymab”,
“rituximab”: “rytuksymab”,
“tocilizumab”: “tocilizumab”,
“osteoporosis”: “osteoporoza”,
“reduced life expectancy”: “skrócona długość życia”,
“exacerbate”: “zaostrzać”,
“hallmark”: “cecha charakterystyczna”,
“butterfly rash”: “rumień motylkowaty”,
“arthritis”: “zapalenie stawów”,
“kidney failure”: “niewydolność nerek”,
“Antinuclear Antibody Test”: “badanie przeciwciał przeciwjądrowych”,
“Complement Levels”: “poziomy dopełniacza”,
“Antimalarials”: “leki przeciwmalaryczne”,
“synovial membrane”: “błona maziowa”,
“fatigue”: “zmęczenie”,
“low-grade fever”: “niskiego stopnia gorączka”,
“malaise”: “złe samopoczucie”,
“Rheumatoid Factor”: “czynnik reumatoidalny”,
“Anti-Citrullinated Protein Antibodies”: “przeciwciała przeciw cytrulinowanym białkom”,
“Biologic Agents”: “leki biologiczne”,
“NSAIDs”: “niesteroidowe leki przeciwzapalne”,
“Corticosteroids”: “kortykosteroidy”,
“HIV/AIDS”: “HIV/AIDS”,
“Human Immunodeficiency Virus”: “Ludzki wirus niedoboru odporności”,
“Retrovirus”: “Retrowirus”,
“CD4 T cells”: “Limfocyty T CD4”,
“Helper T cells”: “Limfocyty T pomocnicze”,
“Acquired Immunodeficiency Syndrome”: “Zespół nabytego niedoboru odporności”,
“Opportunistic infections”: “Zakażenia oportunistyczne”,
“Etiology”: “Etiologia”,
“Transmission”: “Transmisja”,
“Risk Factors”: “Czynniki ryzyka”,
“Pathophysiology”: “Patofizjologia”,
“Immune response”: “Odpowiedź immunologiczna”,
“CD4 cell count”: “Liczba komórek CD4”,
“Opportunistic cancers”: “Nowotwory oportunistyczne”,
“Pneumonia”: “Zapalenie płuc”,
“Tuberculosis”: “Gruźlica”,
“Kaposi’s sarcoma”: “Mięsak Kaposiego”,
“Non-Hodgkin lymphoma”: “Chłoniak nieziarniczy”,
“Lymphadenopathy”: “Powiększenie węzłów chłonnych”,
“Acute retroviral syndrome”: “Ostry zespół retrowirusowy”,
“Chronic HIV Infection”: “Przewlekłe zakażenie HIV”,
“Antibody Tests”: “Testy na przeciwciała”,
“ELISA test”: “Test ELISA”,
“Antigen/Antibody Tests”: “Testy antygenowe/przeciwciał”,
“p24 antigen”: “Antygen p24”,
“Nucleic Acid Tests”: “Testy kwasów nukleinowych”,
“CD4 Count”: “Liczba CD4”,
“Viral Load”: “Wiremia”,
“Disease progression”: “Postęp choroby”,
“Treatment effectiveness”: “Skuteczność leczenia”,
“Antiretroviral Therapy”: “Terapia antyretrowirusowa”,
“Nucleoside Reverse Transcriptase Inhibitors”: “Nukleozydowe inhibitory odwrotnej transkryptazy”,
“Non-Nucleoside Reverse Transcriptase Inhibitors”: “Nienukleozydowe inhibitory odwrotnej transkryptazy”,
“Protease Inhibitors”: “Inhibitory proteazy”,
“Integrase Strand Transfer Inhibitors”: “Inhibitory transferu nici integrazy”,
“Malignancies”: “Nowotwory złośliwe”,
“Cardiovascular Disease”: “Choroba układu sercowo-naczyniowego”,
“Chronic inflammation”: “Przewlekły stan zapalny”,
“Prognosis”: “Rokowanie”,
“10-year survival rate”: “10-letnia przeżywalność”,
“Anaphylaxis”: “Anafilaksja”,
“Allergic reaction”: “Reakcja alergiczna”,
“Systemic symptoms”: “Objawy ogólnoustrojowe”,
“Medications”: “Leki”,
“Antibiotics”: “Antybiotyki”,
“Penicillin”: “Penicylina”,
“Nonsteroidal anti-inflammatory drugs”: “Niesteroidowe leki przeciwzapalne”,
“Vaccines”: “Szczepionki”,
“Venom”: “Jad”,
“Latex”: “Lateks”,
“Allergens”: “Alergeny”,
“Pathophysiology”: “Patofizjologia”,
“Histamine”: “Histamina”,
“Inflammatory mediators”: “Mediatory zapalne”,
“Mast cells”: “Komórki tuczne”,
“Basophils”: “Bazofile”,
“Widespread vasodilation”: “Rozszerzenie naczyń krwionośnych”,
“Vascular permeability”: “Przepuszczalność naczyń krwionośnych”,
“Bronchoconstriction”: “Skurcz oskrzeli”,
“Cutaneous Symptoms”: “Objawy skórne”,
“Urticaria”: “Pokrzywka”,
“Flushing”: “Rumień”,
“Angioedema”: “Obrzęk naczynioruchowy”,
“Respiratory Symptoms”: “Objawy oddechowe”,
“Difficulty breathing”: “Trudności w oddychaniu”,
“Wheezing”: “Świsty oddechowe”,
“Stridor”: “Świst krtaniowy”,
“Gastrointestinal Symptoms”: “Objawy żołądkowo-jelitowe”,
“Nausea”: “Nudności”,
“Vomiting”: “Wymioty”,
“Abdominal cramps”: “Skurcze brzucha”,
“Diarrhea”: “Biegunka”,
“Cardiovascular Symptoms”: “Objawy sercowo-naczyniowe”,
“Rapid heartbeat”: “Przyspieszone bicie serca”,
“Hypotension”: “Niedociśnienie”,
“Fainting”: “Omdlenie”,
“Neurological Symptoms”: “Objawy neurologiczne”,
“Dizziness”: “Zawroty głowy”,
“Loss of consciousness”: “Utrata przytomności”,
“Serum tryptase levels”: “Poziom tryptazy w surowicy”,
“Epinephrine”: “Epinefryna”,
“Vasoconstriction”: “Zwężenie naczyń krwionośnych”,
“Bronchodilation”: “Rozszerzenie oskrzeli”,
“Antihistamines”: “Leki przeciwhistaminowe”,
“Corticosteroids”: “Kortykosteroidy”,
“Emergency Action Plan”: “Plan działania w nagłych przypadkach”,
“Epinephrine auto-injector”: “Autostrzykawka z epinefryną”,
“Biphasic anaphylaxis”: “Anafilaksja dwufazowa”,
“Respiratory distress”: “Zaburzenia oddechowe”,
“Biphasic reaction”: “Reakcja dwufazowa”
};
// Normalize keys in the dictionary
const normalizedWordsToTooltip = {};
for (const [key, value] of Object.entries(wordsToTooltip)) {
const cleanedKey = key.replace(/(.*?)/g, ”).trim(); // Remove anything in parentheses
normalizedWordsToTooltip[cleanedKey.toLowerCase()] = value;
}
function processNode(node) {
if (node.nodeType === Node.TEXT_NODE && node.nodeValue.trim()) {
let content = node.nodeValue;
// Regex to match only the main words (ignores parentheses)
const regex = new RegExp(
`\b(${Object.keys(normalizedWordsToTooltip).join(‘|’)})\b`,
‘gi’
);
if (regex.test(content)) {
const wrapper = document.createElement(‘span’);
wrapper.innerHTML = content.replace(regex, (match) => {
const tooltip = normalizedWordsToTooltip[match.toLowerCase().trim()];
return `
${match}`;
});
node.replaceWith(wrapper);
}
} else if (node.nodeType === Node.ELEMENT_NODE) {
Array.from(node.childNodes).forEach(processNode);
}
}
document.querySelectorAll(‘body *:not(script):not(style)’).forEach((element) => {
Array.from(element.childNodes).forEach(processNode);
});
});
HIV/AIDS
Human Immunodeficiency Virus (HIV) is a retrovirus that attacks the body’s immune system, specifically the CD4 T cells (helper T cells), which are crucial for immune defense. If untreated, HIV can lead to Acquired Immunodeficiency Syndrome (AIDS), a condition characterized by a severely weakened immune system that makes individuals susceptible to opportunistic infections and certain cancers.
Etiology and Risk Factors
- Transmission: HIV is primarily spread through:
- Unprotected sexual contact with an infected person.
- Sharing needles or syringes among people who inject drugs.
- Mother-to-child transmission during childbirth or breastfeeding.
- Exposure to infected blood products (less common in developed countries due to screening).
- Risk Factors:
- Engaging in unprotected sex with multiple partners.
- Having a sexually transmitted infection (STI), which increases susceptibility.
- Sharing injection equipment.
- Receiving unsafe medical practices or transfusions in areas with high HIV prevalence.
Pathophysiology
Once HIV enters the body, it infects and replicates within CD4 T cells, gradually depleting these critical immune cells. This depletion impairs the immune response, making the individual more vulnerable to infections and diseases. The progression from HIV infection to AIDS typically occurs over several years, although the timeline can vary widely among individuals. The CDC defines AIDS as having a CD4 cell count below 200 cells/mm³ or the presence of specific opportunistic infections or cancers.
Clinical Manifestations
- Acute HIV Infection:
- Occurs 2-4 weeks after exposure and may present with flu-like symptoms, including fever, sore throat, fatigue, and lymphadenopathy. This stage is often referred to as acute retroviral syndrome (ARS).
- Chronic HIV Infection:
- This asymptomatic phase can last several years, during which the virus is active but reproducing at low levels. Individuals may not show any symptoms but can still transmit the virus.
- AIDS:
- Characterized by severe immune system damage, individuals may experience recurrent opportunistic infections (e.g., pneumonia, tuberculosis) and specific cancers (e.g., Kaposi’s sarcoma, non-Hodgkin lymphoma). Symptoms may include significant weight loss, chronic diarrhea, prolonged fever, and fatigue.
Diagnostic Approach
- HIV Testing:
- Antibody Tests: Detect the presence of antibodies to HIV in the blood (e.g., ELISA test).
- Antigen/Antibody Tests: Can detect HIV earlier than antibody tests by identifying the p24 antigen.
- Nucleic Acid Tests (NAT): Detects the virus directly and is used in specific cases, such as recent exposures.
- CD4 Count and Viral Load:
- A CD4 count assesses immune function, while viral load testing measures the amount of HIV in the blood, helping to monitor disease progression and treatment effectiveness.
Treatment
- Antiretroviral Therapy (ART): The cornerstone of HIV treatment, ART involves a combination of HIV medicines taken daily to control the virus and prevent progression to AIDS. Key classes of antiretroviral drugs include:
- NRTIs (Nucleoside Reverse Transcriptase Inhibitors)
- NNRTIs (Non-Nucleoside Reverse Transcriptase Inhibitors)
- PIs (Protease Inhibitors)
- INSTIs (Integrase Strand Transfer Inhibitors)
- Regular Monitoring:
- Patients on ART require regular follow-up to monitor CD4 counts, viral loads, and for potential side effects of medications.
Complications
- Opportunistic Infections: Increased susceptibility to infections due to a weakened immune system, requiring prophylactic treatment for those with low CD4 counts.
- Malignancies: Higher risk of cancers, particularly those associated with viral infections, such as Kaposi’s sarcoma and certain lymphomas.
- Cardiovascular Disease: Increased risk due to chronic inflammation and some antiretroviral therapies.
Prognosis
- Good with Treatment: With effective antiretroviral therapy (ART), individuals living with HIV can expect a near-normal life expectancy. Recent studies show that individuals who start ART early can live as long as their HIV-negative peers, with a 10-year survival rate of over 90% for those receiving consistent treatment.
- Progression to AIDS: Without treatment, about 50% of individuals with HIV will progress to AIDS within 10 years. The 5-year survival rate for untreated individuals with AIDS is less than 20%, emphasizing the critical importance of early diagnosis and ongoing management.
Anaphylaxis
Anaphylaxis is a severe, potentially life-threatening allergic reaction that occurs rapidly after exposure to an allergen. It is characterized by systemic symptoms that can affect multiple organ systems and requires immediate medical intervention. Common triggers include foods, medications, insect stings, and latex.
Etiology and Risk Factors
- Common Triggers:
- Foods: Peanuts, tree nuts, shellfish, milk, eggs, and soy are among the most frequent allergens.
- Medications: Antibiotics (such as penicillin), nonsteroidal anti-inflammatory drugs (NSAIDs), and certain vaccines can provoke reactions.
- Insect Stings: Venom from bees, wasps, and fire ants can trigger anaphylaxis in susceptible individuals.
- Latex: Exposure to latex products can induce anaphylactic reactions in sensitive individuals.
- Risk Factors:
- Previous Anaphylaxis: Individuals with a history of anaphylactic reactions are at increased risk for future episodes.
- Allergic Conditions: People with asthma, allergic rhinitis, or other allergic conditions may be more prone to anaphylaxis.
- Genetic Factors: Family history of allergies or anaphylaxis can increase susceptibility.
Pathophysiology
Anaphylaxis is mediated by the immune system’s overreaction to an allergen, leading to the rapid release of histamine and other inflammatory mediators from mast cells and basophils. This process results in widespread vasodilation, increased vascular permeability, and bronchoconstriction. The rapid onset of symptoms can occur within minutes of exposure to the allergen, potentially leading to life-threatening consequences.
Clinical Manifestations
- Cutaneous Symptoms:
- Urticaria (hives), flushing, and angioedema (swelling of the face, lips, or throat) are common initial symptoms.
- Respiratory Symptoms:
- Difficulty breathing, wheezing, and stridor due to bronchoconstriction and swelling of the airways.
- Gastrointestinal Symptoms:
- Nausea, vomiting, abdominal cramps, and diarrhea may occur due to gastrointestinal involvement.
- Cardiovascular Symptoms:
- Rapid heartbeat, hypotension (low blood pressure), and fainting can result from severe vasodilation and decreased blood flow to vital organs.
- Neurological Symptoms:
- Dizziness, confusion, or loss of consciousness can occur due to inadequate perfusion of the brain.
Diagnostic Approach
- Clinical Evaluation: Anaphylaxis is primarily diagnosed based on clinical history and symptom presentation, especially when symptoms occur rapidly after exposure to a known allergen.
- Laboratory Tests:
- While specific tests are not routinely used for diagnosis, serum tryptase levels can be measured within a few hours of anaphylaxis onset to confirm mast cell activation.
Treatment
- Immediate Intervention:
- Epinephrine: The first-line treatment for anaphylaxis is intramuscular epinephrine, which counteracts the symptoms by causing vasoconstriction, bronchodilation, and reducing vascular permeability. Administration should occur as soon as anaphylaxis is suspected.
- Supportive Care:
- Additional treatments may include oxygen supplementation, intravenous fluids, and other medications such as antihistamines and corticosteroids to reduce inflammation and manage symptoms.
- Emergency Action Plan:
- Individuals at risk for anaphylaxis should carry an epinephrine auto-injector and have a written action plan for emergency situations.
Complications
- Recurrent Anaphylaxis: Individuals may experience biphasic anaphylaxis, where symptoms return after initial treatment, typically within 12-72 hours.
- Respiratory Complications: Severe respiratory distress or failure can occur if not promptly treated.
- Psychological Impact: Anxiety and fear of future reactions can significantly affect the quality of life in individuals with a history of anaphylaxis.
Prognosis
- Generally Favorable with Prompt Treatment: With immediate administration of epinephrine, most individuals recover from anaphylaxis without long-term complications. However, the severity of the initial reaction can vary, and those with a history of anaphylaxis are at higher risk for future episodes. Approximately 20% of individuals who experience anaphylaxis will have a biphasic reaction.
